Related Experiment Video
Updated: Jul 19, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
The Too Many Faces of PD-L1: A Comprehensive Conformational Analysis Study
Marawan Ahmed1, Khaled Barakat1
1Faculty of Pharmacy and Pharmaceutical Sciences, and ‡Li Ka Shing Institute of Virology, University of Alberta , Edmonton, Alberta, Canada.
Researchers explored the programmed cell death protein 1 (PD-1) pathway, focusing on PD-L1 dynamics. Computational analysis revealed flexible regions and a key methionine residue influencing drug binding, aiding new cancer therapy development.
Area of Science:
- Structural Biology
- Computational Chemistry
- Immunology
Background:
- The programmed cell death protein 1 (PD-1) pathway is a critical regulator of the immune system.
- Dysregulation of the PD-1/PD-L1 axis is implicated in various cancers, making it a target for immunotherapy.
- Understanding the structural dynamics of PD-L1 is crucial for designing effective inhibitors.
Purpose of the Study:
- To investigate the conformational dynamics of the PD-L1 protein.
- To identify key regions and residues involved in PD-L1 structural flexibility and ligand binding.
- To provide computational insights into the binding mechanisms of PD-L1 for drug discovery.
Main Methods:
- Principal Component Analysis (PCA) of existing PD-L1 crystal structures.
- Classical and accelerated molecular dynamics (MD) simulations.
- Analysis of structural displacements and flexible regions within PD-L1.
Main Results:
- Identified maximum structural displacements in PD-L1 across crystal structures and MD simulations.
- Attributed protein flexibility to specific regions within the PD-L1 structure.
- Highlighted a methionine residue at the binding site crucial for small molecule interaction.
Conclusions:
- The study elucidates PD-L1 conformational dynamics and flexibility.
- Identified a key methionine residue critical for drug binding interactions.
- Provides valuable computational data to support the development of novel therapies targeting the PD-1 immune-checkpoint pathway.
More Related Videos
09:40Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes
Published on: September 28, 2018
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology